69 related articles for article (PubMed ID: 22445302)
21. Intercostal Recession and Bulging during Pendelluft Detected in Four-Dimensional Computed Tomography.
Katayama S; Tonai K; Atsuko S
Am J Respir Crit Care Med; 2023 Nov; 208(10):e41-e43. PubMed ID: 37672024
[No Abstract] [Full Text] [Related]
22. Evaluation of Clinician Contouring for Pancreatic Stereotactic Ablative Radiotherapy During a Contouring Workshop Organised by the Royal College of Radiologists.
Slevin F; Beasley M; Speight R; Lilley J; Murray L; Hawkins M; Radhakrishna G; Henry A
Clin Oncol (R Coll Radiol); 2021 Mar; 33(3):e196-e197. PubMed ID: 33129654
[No Abstract] [Full Text] [Related]
23. Chest Magnetic Resonance Imaging Decreases Inter-observer Variability of Gross Target Volume for Lung Tumors.
Basson L; Jarraya H; Escande A; Cordoba A; Daghistani R; Pasquier D; Lacornerie T; Lartigau E; Mirabel X
Front Oncol; 2019; 9():690. PubMed ID: 31456936
[No Abstract] [Full Text] [Related]
24. Integrating Small Animal Irradiators withFunctional Imaging for Advanced Preclinical Radiotherapy Research.
Ghita M; Brown KH; Kelada OJ; Graves EE; Butterworth KT
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30717307
[TBL] [Abstract][Full Text] [Related]
25. The developing role of FDG PET imaging for prognostication and radiotherapy target volume delineation in non-small cell lung cancer.
Konert T; van de Kamer JB; Sonke JJ; Vogel WV
J Thorac Dis; 2018 Aug; 10(Suppl 21):S2508-S2521. PubMed ID: 30206495
[TBL] [Abstract][Full Text] [Related]
26. T2-Weighted 4D Magnetic Resonance Imaging for Application in Magnetic Resonance-Guided Radiotherapy Treatment Planning.
Freedman JN; Collins DJ; Bainbridge H; Rank CM; Nill S; Kachelrieß M; Oelfke U; Leach MO; Wetscherek A
Invest Radiol; 2017 Oct; 52(10):563-573. PubMed ID: 28459800
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of target volumes based on
Guo Y; Li J; Zhang P; Zhang Y
Onco Targets Ther; 2017; 10():177-184. PubMed ID: 28123302
[TBL] [Abstract][Full Text] [Related]
28. [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.
Wyss JC; Carmona R; Karunamuni RA; Pritz J; Hoh CK; Mell LK
Radiother Oncol; 2016 Jan; 118(1):72-8. PubMed ID: 26674924
[TBL] [Abstract][Full Text] [Related]
29. Image-guided radiotherapy and motion management in lung cancer.
Korreman SS
Br J Radiol; 2015 Jul; 88(1051):20150100. PubMed ID: 25955231
[TBL] [Abstract][Full Text] [Related]
30. Geographic miss of lung tumours due to respiratory motion: a comparison of 3D vs 4D PET/CT defined target volumes.
Callahan J; Kron T; Siva S; Simoens N; Edgar A; Everitt S; Schneider ME; Hicks RJ
Radiat Oncol; 2014 Dec; 9():291. PubMed ID: 25511904
[TBL] [Abstract][Full Text] [Related]
31. 4D PET/CT as a Strategy to Reduce Respiratory Motion Artifacts in FDG-PET/CT.
Chi A; Nguyen NP
Front Oncol; 2014; 4():205. PubMed ID: 25136514
[TBL] [Abstract][Full Text] [Related]
32. Comparison of primary target volumes delineated on four-dimensional CT and 18 F-FDG PET/CT of non-small-cell lung cancer.
Duan YL; Li JB; Zhang YJ; Wang W; Li FX; Sun XR; Guo YL; Shang DP
Radiat Oncol; 2014 Aug; 9():182. PubMed ID: 25123450
[TBL] [Abstract][Full Text] [Related]
33. Defining internal target volume using positron emission tomography for radiation therapy planning of moving lung tumors.
Riegel AC; Bucci MK; Mawlawi OR; Ahmad M; Luo D; Chandler A; Pan T
J Appl Clin Med Phys; 2014 Jan; 15(1):4600. PubMed ID: 24423860
[TBL] [Abstract][Full Text] [Related]
34. Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer.
Duan Y; Li J; Zhang Y; Wang W; Sun X; Fan T; Shao Q; Xu M; Guo Y; Shang D
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):623-30. PubMed ID: 25754243
[TBL] [Abstract][Full Text] [Related]
35. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer.
Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z
Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760
[TBL] [Abstract][Full Text] [Related]
36. Residual ¹⁸F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control.
Bollineni VR; Widder J; Pruim J; Langendijk JA; Wiegman EM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e551-5. PubMed ID: 22417800
[TBL] [Abstract][Full Text] [Related]
37. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
38. Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.
Na F; Wang J; Li C; Deng L; Xue J; Lu Y
J Thorac Oncol; 2014 Jun; 9(6):834-42. PubMed ID: 24787963
[TBL] [Abstract][Full Text] [Related]
39. Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography.
Hanna GG; van Sörnsen de Koste JR; Dahele MR; Carson KJ; Haasbeek CJ; Migchielsen R; Hounsell AR; Senan S
Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):e71-80. PubMed ID: 22445302
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
